Literature DB >> 3949188

The Kayser-Fleischer ring during long-term treatment in Wilson's disease (hepatolenticular degeneration). A follow-up study.

A Lössner, J Lössner, H Bachmann, J Zotter.   

Abstract

The role of Kayser-Fleischer rings is described in 67 patients with Wilson's disease, both in the asymptomatic and symptomatic stage of the disease during life-long therapy, which lasted up to 22 years. The rings were missing in 60% of patients in the presymptomatic stage and in 2% of those in the symptomatic stage at the time of diagnosis. The Kayser-Fleischer rings disappeared in 81% of the patients (completely in 41% and incompletely in 59%). In 2 of the 6 asymptomatic patients the rings did not reabsorb even after therapy of more than 10 years. The fading of Kayser-Fleischer rings seems to be independent not only of the stage of the disease but also of the effectiveness of the decopperizing treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949188     DOI: 10.1007/bf02141489

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Presymptomatic Wilson's disease.

Authors:  A J Levi; S Sherlock; P J Scheuer; J N Cumings
Journal:  Lancet       Date:  1967-09-16       Impact factor: 79.321

2.  Ultrastructure of the Kayser-Fleischer ring.

Authors:  B L Johnson
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

3.  Kayser-Fleischer ring. A pathological study.

Authors:  J Harry; R Tripathi
Journal:  Br J Ophthalmol       Date:  1970-12       Impact factor: 4.638

4.  Disappearance of Kayser-Fleischer rings. Effects of penicillamine.

Authors:  W Sussman; I H Scheinberg
Journal:  Arch Ophthalmol       Date:  1969-12

5.  [Wilson's disease in the German Democratic Republic. I. Genetics and epidemiology].

Authors:  H Bachmann; J Lössner; D Biesold
Journal:  Z Gesamte Inn Med       Date:  1979-12-15

6.  [Wilson's disease in the German Democratic Republic. III. Diagnosis and therapy].

Authors:  J Lössner; W Storch; H Bachmann; D Biesold; H J Kühn
Journal:  Z Gesamte Inn Med       Date:  1980-02-15

7.  Long-term therapy of Wilson's disease.

Authors:  A Deiss; R E Lynch; G R Lee; G E Cartwright
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

8.  Non-invasive quantitation of corneal copper in hepatolenticular degeneration (Wilson's disease).

Authors:  M Belkin; R Zeimer; T Chajek; G Friedman; E Melamed
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

9.  [Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].

Authors:  H Hiti; H Harpf; W Wutz; O Schmut
Journal:  Klin Monbl Augenheilkd       Date:  1980-02       Impact factor: 0.700

10.  Diagnostic dilemmas of Wilson's disease: diagnosis and treatment.

Authors:  S L Werlin; R J Grand; J A Perman; J B Watkins
Journal:  Pediatrics       Date:  1978-07       Impact factor: 7.124

View more
  8 in total

Review 1.  Classification and differential diagnosis of Wilson's disease.

Authors:  Wieland Hermann
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Diagnosis and treatment of Wilson's disease.

Authors:  Indu Subramanian; Zeba F Vanek; Jeff M Bronstein
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

3.  The Hematologic Definition of Monoclonal Gammopathy of Undetermined Significance in Relation to Paraproteinemic Keratopathy (An American Ophthalmological Society Thesis).

Authors:  Walter Lisch; Joanna Wasielica-Poslednik; Tero Kivelä; Ursula Schlötzer-Schrehardt; Jens M Rohrbach; Walter Sekundo; Uwe Pleyer; Christina Lisch; Alexander Desuki; Heidi Rossmann; Jayne S Weiss
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

4.  Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration.

Authors:  C Hartard; B Weisner; C Dieu; K Kunze
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

5.  Investigation of corneal topographic and densitometric properties of Wilson's disease patients with or without a Kayser-Fleischer ring.

Authors:  Mehmet Fuat Alakus; Mehtap Caglayan; Nazım Ekin; Hasan Oncul; Esref Arac; Umut Dag; Halit Diri
Journal:  Eye Vis (Lond)       Date:  2021-03-11

Review 6.  Chelation therapy in liver diseases of childhood: Current status and response.

Authors:  Jayendra Seetharaman; Moinak Sen Sarma
Journal:  World J Hepatol       Date:  2021-11-27

7.  The sunflower cataract in Wilson's disease: pathognomonic sign or rare finding?

Authors:  Ewa Langwińska-Wośko; Tomasz Litwin; Karolina Dzieżyc; Anna Członkowska
Journal:  Acta Neurol Belg       Date:  2015-11-17       Impact factor: 2.396

8.  A 10-year-old boy with dystonia, expression-less facies, and tremors referred for ophthalmic examination.

Authors:  Koushik Tripathy; Ankit Singh Tomar; Talvir Sidhu; Tanuj Dada
Journal:  Oman J Ophthalmol       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.